These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3728150)

  • 1. The biochemical mechanism of metabolic cooperation.
    Koenker R; Luchtman LA; Willis RC; Seegmiller JE; Gruber HE
    Adv Exp Med Biol; 1986; 195 Pt A():183-7. PubMed ID: 3728150
    [No Abstract]   [Full Text] [Related]  

  • 2. High HPRT activity in fibroblasts from patients with Lesch-Nyhan syndrome due to bacterial "L-form" contamination.
    Willers I; Singh S; Held KR; Goedde HW
    Adv Exp Med Biol; 1980; 122A():327-31. PubMed ID: 7424651
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathogenesis of the Lesch-Nyhan syndrome: ATP use is positively related to hypoxanthine supply to hypoxanthine guanine phosphoribosyltransferase.
    Harkness RA; McCreanor GM; Greenwood R
    J Inherit Metab Dis; 1991; 14(2):202-14. PubMed ID: 1886405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity of hypoxanthine-phosphoribosyl transferase in human fibroblasts of 3 families.
    Willers I; Held KR; Singh S; Goedde HW
    Clin Genet; 1977 Mar; 11(3):193-200. PubMed ID: 837570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished affinity for purine substrates as a basis for gout with mild deficiency of hypoxanthine-guanine phosphoribosyltransferase.
    Sweetman L; Borden M; Lesh P; Bakay B; Becker MA
    Adv Exp Med Biol; 1977; 76A():319-25. PubMed ID: 558714
    [No Abstract]   [Full Text] [Related]  

  • 6. Lesch-Nyhan syndrome: biochemical characterization of a case with attenuated behavioral manifestation.
    Fattal A; Spirer Z; Zoref-Shani E; Sperling O
    Enzyme; 1984; 31(1):55-60. PubMed ID: 6201351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of hypoxanthine-guanine phosphoribosyltransferase deficiency in man.
    Wilson JM; Kelley WN
    Arch Intern Med; 1985 Oct; 145(10):1895-1900. PubMed ID: 3899038
    [No Abstract]   [Full Text] [Related]  

  • 9. An atypical case of hypoxanthine-guanine phosphoribosyltransferase deficiency (Lesch-Nyhan syndrome). II. Genetic studies.
    de Bruyn CH; Oei TL; Geerdink RA; Lommen EJ
    Clin Genet; 1973; 4(4):353-9. PubMed ID: 4747812
    [No Abstract]   [Full Text] [Related]  

  • 10. Lesch-Nyhan syndrome: incorporation of hypoxanthine in stimulated lymphocytes.
    de Bruyn CH; Oei TL
    Exp Cell Res; 1973 Jun; 79(2):450-2. PubMed ID: 4798705
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigation of purine utilization in cultured fibroblasts, amniocytes and chorionic villi: an attempt towards understanding clinical variability in Lesch-Nyhan syndrome.
    Singh S; Willers I; Held K; Godde HW
    Adv Exp Med Biol; 1986; 195 Pt A():143-51. PubMed ID: 3728147
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of phorbols on metabolic cooperation between human fibroblasts.
    Mosser DD; Bols NC
    Carcinogenesis; 1982; 3(10):1207-12. PubMed ID: 7172420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxanthine-guanine phosphoribosyltransferase deficiency: chemical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygote cultures.
    Fujimoto WY; Subak-Sharpe JH; Seegmiller JE
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1516-9. PubMed ID: 5283941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase activity decreased in cells lacking hypoxanthine phosphoribosyltransferase activity.
    Breakefield XO; Castiglione CM; Edelstein SB
    Science; 1976 Jun; 192(4243):1018-20. PubMed ID: 1273584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Lesch-Nyhan heterozygotes by peripheral blood.
    Kamatani N; Yamanaka H; Nishioka K; Nishida Y; Mikanagi K
    Adv Exp Med Biol; 1986; 195 Pt A():157-62. PubMed ID: 3728148
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitation of metabolic cooperation by measurement of HGPRTase activity.
    Vitkauskas G; Canellakis ES
    Exp Cell Res; 1985 Feb; 156(2):537-43. PubMed ID: 2578405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical correlates of a new HPRT mutation.
    Gruber HE; Vuchinich M; Marlow TA; Plent MM; Willis RC; Seegmiller JE; Bartley J; Hanson JW; Zellweger H
    Adv Exp Med Biol; 1984; 165 Pt A():19-22. PubMed ID: 6720378
    [No Abstract]   [Full Text] [Related]  

  • 18. Glial cells metabolically cooperate: a potential requirement for gene replacement therapy.
    Gruber HE; Koenker R; Luchtman LA; Willis RC; Seegmiller JE
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6662-6. PubMed ID: 2995977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesch-Nyhan disease.
    Nyhan WL
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):559-63. PubMed ID: 18600504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoribosylpyrophosphate overproduction, a new metabolic abnormality in the Lesch Nyhan syndrome.
    Reem GH
    Science; 1975 Dec; 190(4219):1098-9. PubMed ID: 171772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.